Mobile Application for Gastroesophageal Reflux Disease (NCT07744815) | Clinical Trial Compass
CompletedNot Applicable
Mobile Application for Gastroesophageal Reflux Disease
Taiwan90 participantsStarted 2025-09-15
Plain-language summary
Gastroesophageal reflux disease (GERD) is a chronic condition with frequent symptom recurrence that may negatively affect sleep quality and quality of life. This randomized controlled study aims to evaluate whether a mobile application developed as a mobile application, combined with standard education and diaphragmatic breathing training, can reduce symptom recurrence and improve sleep quality and quality of life in patients with GERD. Participants will be randomly assigned to either an intervention group receiving the mobile application or a control group receiving standard education. Outcomes will be assessed using the GerdQ, Reflux Symptom Index (RSI), GERD-HRQL, and Insomnia Severity Index (ISI) at baseline, 2 weeks, 4 weeks, and 8 weeks.
Who can participate
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
.Owns and is able to use a smartphone.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial used a mobile app to track or manage GERD symptom severity — can you tell me what the app actually involved and whether the results showed any meaningful improvement in symptoms compared to standard care?
2Since this trial is already completed, have the findings been published anywhere, and do you think the approach it tested — using a mobile app for GERD — is something that might be relevant to managing my own condition?
3This was listed as a 'Phase NA' study, which often means it was more of a behavioral or device-based intervention rather than a drug trial — does that affect how confident you are in the safety and effectiveness of what was tested?
4If the app-based approach from this trial showed promise, is there any way I could access something similar right now, or is it still considered experimental in your view?
5Given that my diagnosis involves gastroesophageal reflux esophagitis, do you think a digital symptom-tracking tool like the one in this trial would add value to my current treatment plan, or would focusing on medication and lifestyle changes be a better first step?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
GERD Symptom severity
Timeframe: Baseline, 2 weeks, 4 weeks, and 8 weeks